CDRI-99-373

N/A

Report date: 2025/01/26 17:58:40
NME

Base Information

Drug NameCDRI-99-373
Drug Alias Namebone metabolism modulator (CDRI)CDRI-99-373
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEstrogen receptor alpha modulatorsTransforming growth factor beta 3 modulatorsCalcitonin receptor modulators
TargetsTransforming growth factor beta 3Calcitonin receptorEstrogen receptor alpha
Therapy Area/IndicationsOsteoporosis, PostmenopausalOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCentral Drug Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesCentral Drug Research Institute
Inactive CompaniesN/A
Active IndicationsOsteoporosis, Postmenopausal
Inactive IndicationsOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A